Back

Cost and Clinical Utility of WES and WGS in pediatric patients with suspected genetic disease

2022-10-13 genetic and genomic medicine Title + abstract only
View on medRxiv
Show abstract

Payer coverage for Exome Sequencing (ES) is becoming commonplace (albeit in some cases with prior authorization restrictions), coverage for Genome Sequencing (GS) is rare, with most payers considering it as investigational and not medically necessary. Previous studies had identified several concerns and challenges from the payer perspective. The objective of this study is to conduct a targeted literature review of the evidence describing the cost and clinical utility of GS and ES compared to sta...

Predicted journal destinations

1
Genetics in Medicine
57 training papers
#1 50.9%
2
The American Journal of Human Genetics
77 training papers
Top 2% 7.9%
3
European Journal of Human Genetics
25 training papers
Top 0.2% 5.2%
4
Genome Medicine
56 training papers
Top 3% 4.8%
5
PLOS ONE
1737 training papers
Top 91% 2.4%
6
Journal of Medical Genetics
22 training papers
Top 0.6% 2.4%
7
Human Genetics and Genomics Advances
39 training papers
Top 3% 1.9%
8
Scientific Reports
701 training papers
Top 81% 1.9%
9
Nature Genetics
72 training papers
Top 7% 1.7%
10
npj Genomic Medicine
18 training papers
Top 1% 1.5%
11
PLOS Genetics
39 training papers
Top 5% 1.5%
12
Genes
21 training papers
Top 2% 1.4%
13
Nature Communications
483 training papers
Top 50% 1.2%
14
Human Molecular Genetics
28 training papers
Top 6% 1.2%
15
Frontiers in Genetics
32 training papers
Top 6% 1.2%
16
The Journal of Molecular Diagnostics
24 training papers
Top 2% 0.9%
17
Cell Genomics
34 training papers
Top 7% 0.9%
18
BMJ Open
553 training papers
Top 70% 0.6%
19
Bioinformatics
24 training papers
Top 5% 0.6%
20
Circulation: Genomic and Precision Medicine
30 training papers
Top 8% 0.6%
21
Movement Disorders
49 training papers
Top 8% 0.6%